国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
5期
620-623
,共4页
付艳%毕益明%陈秀芳%陈兴秀%江志勇%郑东星%王淑燕
付豔%畢益明%陳秀芳%陳興秀%江誌勇%鄭東星%王淑燕
부염%필익명%진수방%진흥수%강지용%정동성%왕숙연
恶性肿瘤%泛发性带状疱疹%治疗
噁性腫瘤%汎髮性帶狀皰疹%治療
악성종류%범발성대상포진%치료
Malignant tumors%Disseminated Herpes zoster%Treatment
目的 对恶性肿瘤伴发的泛发性带状疱疹的治疗进行探讨,并与恶性肿瘤伴发的局限于单侧的带状疱疹进行统计学分析.方法 回顾分析我院自2000年1月至2011年7月住院期间共收治9例泛发性带状疱疹病人,同期收治恶性肿瘤伴发局限性带状疱疹28例,并对其进行统计学分析.结果 恶性肿瘤伴发泛发性带状疱疹患者CD4/CD8降低比例为44.44%(4/9),恶性肿瘤伴有单纯性带状疱疹患者CD4/CD8降低比例为10.71%(3/28);二者比较有统计学意义(P<0.05).恶性肿瘤伴发泛发性带状疱疹患者结痂时间平均为(7.44±1.92)天,恶性肿瘤伴发单纯性带状疱疹患者结痂时间平均为(3.89±0.598)天,二者比较有显著统计学差异(P<0.01).结论 恶性肿瘤伴发泛发性带状疱疹患者免疫功能低于恶性肿瘤伴发单纯性带状疱疹患者,且治疗后结痂时间长于后者.
目的 對噁性腫瘤伴髮的汎髮性帶狀皰疹的治療進行探討,併與噁性腫瘤伴髮的跼限于單側的帶狀皰疹進行統計學分析.方法 迴顧分析我院自2000年1月至2011年7月住院期間共收治9例汎髮性帶狀皰疹病人,同期收治噁性腫瘤伴髮跼限性帶狀皰疹28例,併對其進行統計學分析.結果 噁性腫瘤伴髮汎髮性帶狀皰疹患者CD4/CD8降低比例為44.44%(4/9),噁性腫瘤伴有單純性帶狀皰疹患者CD4/CD8降低比例為10.71%(3/28);二者比較有統計學意義(P<0.05).噁性腫瘤伴髮汎髮性帶狀皰疹患者結痂時間平均為(7.44±1.92)天,噁性腫瘤伴髮單純性帶狀皰疹患者結痂時間平均為(3.89±0.598)天,二者比較有顯著統計學差異(P<0.01).結論 噁性腫瘤伴髮汎髮性帶狀皰疹患者免疫功能低于噁性腫瘤伴髮單純性帶狀皰疹患者,且治療後結痂時間長于後者.
목적 대악성종류반발적범발성대상포진적치료진행탐토,병여악성종류반발적국한우단측적대상포진진행통계학분석.방법 회고분석아원자2000년1월지2011년7월주원기간공수치9례범발성대상포진병인,동기수치악성종류반발국한성대상포진28례,병대기진행통계학분석.결과 악성종류반발범발성대상포진환자CD4/CD8강저비례위44.44%(4/9),악성종류반유단순성대상포진환자CD4/CD8강저비례위10.71%(3/28);이자비교유통계학의의(P<0.05).악성종류반발범발성대상포진환자결가시간평균위(7.44±1.92)천,악성종류반발단순성대상포진환자결가시간평균위(3.89±0.598)천,이자비교유현저통계학차이(P<0.01).결론 악성종류반발범발성대상포진환자면역공능저우악성종류반발단순성대상포진환자,차치료후결가시간장우후자.
Objective To explore the treatment for malignant tumors complicated with disseminated herpes zoster, and then compare with malignant tumors complicated with unilateral herpes zoster.Methods The data on 9 patients with malignant tumors and complicated with disseminated herpes zoster who had been treated from January 2000 to July 2011 were retrospectively analyzed,and so were the data on the 28 patients complicated with unilateral herpes zoster herpes zoster who had been treated during the same time.Results There was a significant difference in the CD4/CD8 rate between the patients with disseminated herpes zoster and those with unilateral herpes zoster ( 44.44% vs.10.71% or 4/9 vs.3/28,P < 0.05 ).Time to scar formation differed significantly between the patients with disseminated herpes and those with unilateral herpes zoster ( [7.44 ± 1.926]d vs.[3.89 ± 0.598]d,P<0.01 ).Conclusions The immune function is weaker in malignant tumor patients complicated with disseminated herpes zoster than in those with local herpes zoster.Time to scar formation is also longer in the patients with disseminated herpes zoster.